VITALE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 8.235
EU - Europa 3.361
AS - Asia 2.697
SA - Sud America 429
AF - Africa 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.768
Nazione #
US - Stati Uniti d'America 8.158
GB - Regno Unito 1.421
CN - Cina 1.009
SG - Singapore 843
IT - Italia 465
BR - Brasile 362
HK - Hong Kong 356
SE - Svezia 352
DE - Germania 288
RU - Federazione Russa 160
UA - Ucraina 156
VN - Vietnam 150
FI - Finlandia 117
FR - Francia 114
KR - Corea 92
TR - Turchia 87
IE - Irlanda 83
BG - Bulgaria 66
CA - Canada 46
IN - India 41
AR - Argentina 26
ID - Indonesia 26
NL - Olanda 22
ZA - Sudafrica 19
BE - Belgio 18
MX - Messico 18
BD - Bangladesh 17
ES - Italia 16
BY - Bielorussia 13
EC - Ecuador 12
JP - Giappone 11
MY - Malesia 11
PL - Polonia 11
CL - Cile 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
PY - Paraguay 7
CO - Colombia 6
RO - Romania 6
VE - Venezuela 6
AT - Austria 5
PK - Pakistan 5
PT - Portogallo 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
IL - Israele 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
NO - Norvegia 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AU - Australia 2
CR - Costa Rica 2
DZ - Algeria 2
JO - Giordania 2
LU - Lussemburgo 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
AD - Andorra 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TW - Taiwan 1
Totale 14.768
Città #
Southend 1.111
Fairfield 803
Santa Clara 788
Ashburn 743
Woodbridge 562
Singapore 499
Chandler 464
Houston 406
Hefei 366
Seattle 356
Hong Kong 350
Jacksonville 347
Dearborn 291
Wilmington 291
Cambridge 290
Ann Arbor 288
Chicago 228
Nyköping 201
Beijing 182
Los Angeles 168
London 158
Modena 115
Salt Lake City 86
Dublin 83
New York 80
Seoul 76
Princeton 75
San Diego 67
Sofia 63
Eugene 57
Helsinki 55
Izmir 53
Dallas 52
Council Bluffs 50
Moscow 47
Buffalo 46
The Dalles 46
Ho Chi Minh City 43
Elk Grove Village 42
Des Moines 39
São Paulo 35
Bremen 32
Frankfurt am Main 29
Munich 29
Milan 28
Redwood City 28
Tampa 28
Fremont 27
Toronto 27
Boardman 24
Falls Church 24
Hanoi 24
Lancaster 24
Phoenix 24
Columbus 21
Shanghai 20
Sterling 18
Brooklyn 17
Norwalk 17
Brussels 16
Miami 15
Bologna 13
Jakarta 13
Rome 13
Seongnam 13
Parma 12
Pittsburgh 12
Detroit 11
Johannesburg 11
Kansas City 11
Paris 11
Poplar 11
Warsaw 11
Wuhan 11
Biên Hòa 10
Kent 10
Nanjing 10
Naples 10
Rio de Janeiro 10
Tokyo 10
Denver 9
Dong Ket 9
Dulles 9
Chennai 8
Formia 8
Hounslow 8
Montreal 8
Orem 8
Reggio Emilia 8
San Mateo 8
Ankara 7
Brasília 7
Gif-sur-Yvette 7
Guayaquil 7
Hangzhou 7
Jinan 7
Redondo Beach 7
Turku 7
Verona 7
Amsterdam 6
Totale 10.939
Nome #
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 450
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 379
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 373
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 372
Acute noise stress analgesia in relation to 5-HT2 and mu-opioid receptor changes in the frontal cortex of young mice 371
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 342
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 326
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 321
Collagen VI regulates peripheral nerve regeneration by modulating macrophage recruitment and polarization 296
Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet 294
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 293
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 290
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 288
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 283
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 281
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 279
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 275
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 275
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 264
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 260
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 260
Gamma-hydroxybutyrate increases gastric emptying in rats 247
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 242
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 241
Headaches associated with chronic use of analgesics: A therapeutic approach 233
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 231
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 231
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 230
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 228
Effect of rofecoxib on nociception and the serotonin system in the rat brain 226
BV-2 Microglial Cells Respond to Rotenone Toxic Insult by Modifying Pregnenolone, 5alpha-Dihydroprogesterone and Pregnanolone Level 226
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 223
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 222
Disposition of naproxen after oral administration during and between migraine attacks. 221
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 219
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 219
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 212
In vitro toxicity of fibrous glaucophane 211
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 203
Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy 203
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 201
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 198
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 197
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 195
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 192
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 192
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 186
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 186
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 182
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 176
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 174
Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models 169
Effect of hypericum perforatum extract in an experimental model of binge eating in female rats 166
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 166
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 165
Chronic treatment with phenazone modifies pontine noradrenergic receptors in rats. 163
EFFECTS OF ACETYLSALICYCLIC ACID ON SEROTONIN BRAIN RECEPTOR SUBTYPES 158
Naloxone-reverisble antinociception by paracetamol in the rat. 149
Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes 147
Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence 145
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis 133
Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis 126
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study 108
Chemical Characterization and Beneficial Effects of Walnut Oil on a Drosophila melanogaster Model of Parkinson’s Disease 105
Characterization of Walnut Oil and Evaluation of Its Neuroprotective Effects in an In Vitro Model of Parkinson’s Disease 50
Totale 14.869
Categoria #
all - tutte 60.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021853 0 0 0 0 0 130 106 169 63 209 89 87
2021/20221.318 40 156 157 76 37 37 101 64 148 99 257 146
2022/20231.341 163 152 86 124 147 207 22 118 137 30 55 100
2023/2024650 36 36 49 54 162 43 34 93 11 17 52 63
2024/20252.692 86 16 44 176 566 388 225 136 298 160 293 304
2025/20263.202 405 273 437 779 1.126 182 0 0 0 0 0 0
Totale 14.869